Myriad Genetics Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
70.92 M |
Public Float |
44.82 M |
Myriad Genetics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.3 |
Market Cap |
$2.03 B |
Shares Outstanding |
73.37 M |
Public Float |
71.43 M |
Address |
320 Wakara Way Salt Lake City Utah 84108 United States |
Employees | - |
Website | http://www.myriad.com |
Updated | 07/08/2019 |
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through Diagnostics and Other segments. The Diagnostics segment engages in the provision of testing and collaborative development of testing that is designed to asses a risk of developing a disease later in life of an individual. |